PPT-Crysvita ® ( burosumab-twza PowerPoint Presentation

A Summary of Clinical Trial Data MRCPKRN2300318 518 Crysvita Overview Indications and Usage Crysvita is a fibroblast growth factor 23 FGF23 blocking antibody

Upload by eleanor
Published on 2024-03-13

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/1047078" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Crysvita ® ( burosumab-twza" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Crysvita ® ( burosumab-twza: Transcript

PPT-Crysvita ® ( burosumab-twza PowerPoint Presentation

Presentation Embed Code

Download Presentation

Crysvita ® ( burosumab-twza: Transcript

Related Contents